ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,231,000 | +37.1% | 7,154 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $898,000 | -7.4% | 7,154 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $970,000 | +6.0% | 7,154 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $915,000 | +13.7% | 7,154 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $805,000 | +18.0% | 7,154 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $682,000 | +6.1% | 7,154 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $643,000 | +273.8% | 7,154 | +120.4% | 0.00% | +300.0% |
| Q4 2019 | $172,000 | +34.4% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $128,000 | -3.8% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $133,000 | -11.9% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $151,000 | +7.1% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $141,000 | -24.2% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $186,000 | +18.5% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $157,000 | +23.6% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $127,000 | -8.0% | 3,246 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $138,000 | – | 3,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |